Trazium esilate
Alternative Names: EGYT 3615Latest Information Update: 15 Aug 2007
At a glance
- Originator Egis Pharmaceuticals
- Class Antidepressants; Small molecules
- Mechanism of Action Adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 07 Jan 1997 No-Development-Reported for Depression in Hungary (Unknown route)